Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,248 public trials 1,189 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma

NCT00413075

Conditions
Adenoma, Adenosarcoma, Adnexal Diseases, +89 more
Locations
  • Yale New Haven Hospital New Haven, Connecticut, United States
  • Columbia University - Herbert Irving Cancer Center New York, United States
  • New York University Cancer Institute New York, United States
  • M.D. Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

A Study of Alimta/Cisplatin/Gefitinib for Asian Non-smoking Participants With Non Small Cell Lung Cancer

NCT01017874

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kowloon, Hong Kong
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Singapore
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Incheon, South Korea
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, South Korea
View Trial Details
Completed

Safety and Effect of Pertuzumab in Patients With Advanced Non-Small Cell Lung Cancer, Which Has Progressed After Prior Chemotherapy

NCT00063154

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Arizona Cancer Center Scottsdale, Arizona, United States
  • Arizona Cancer Center Tucson, Arizona, United States
  • Cedars-Sinai Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Cancer Center Sacramento, California, United States
View Trial Details
Completed

Study of Gleevec and Weekly Paclitaxel in Patients Aged 70 or Older With Advanced Non-small Cell Lung Cancer

NCT01011075

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • University of New Mexico Cancer Center @ Lovelace Medical Center Albuquerque, New Mexico, United States
  • University of New Mexico Cancer Center Albuquerque, New Mexico, United States
  • Univ. of Washington Fred Hutchinson Cancer Research Center (UW-FHCRC) Seattle, Washington, United States
View Trial Details
Completed

Icotinib in Advanced Metastatic Patients With NSCLC Previously Treated With Chemotherapy

NCT02486354

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Cancer Hospital, Chinese Academy of Medical Science Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Bejing Cancer Hospital Beijing, Beijing Municipality, China
  • 307 Hospital of PLA Beijing, Beijing Municipality, China
View Trial Details
Completed

Powered Echelon Device in VATS Surgery

NCT01843192

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Dignity Health, St. Joseph's Hospital & Medical Center Phoenix, Arizona, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Vanderbilt University Nashville, Tennessee, United States
View Trial Details
Completed

A Study of Induction and Maintenance Treatment of Advanced or Metastatic Non Squamous Non-Small Cell Lung Cancer

NCT00867009

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Graz, Austria
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Salzburg, Austria
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wels, Austria
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany
View all 24 locations
View Trial Details
Completed

Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC

NCT00621049

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Northeast Alabama Medical Center Anniston, Alabama, United States
  • Northeast Arkansas Clinic Jonesboro, Arkansas, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Gulfcoast Oncology Associates St. Petersburg, Florida, United States
View all 26 locations
View Trial Details

Related conditions